Researchers have turned a staple protein in every cell into a drug capable of thwarting the virus that causes Middle East Respiratory Syndrome or MERS. Because the technology can be applied to a wide range of pathogens the researchers believe that it could become a game-changer in anti-viral therapeutics with implications for human health and the farming industry. Vaccines are important for prevention but there is a great need for anti-viral medicines to treat people who have become infected said Wei Zhang from the University of Toronto in Canada. MERS is similar to SARS the virus that killed almost 800
